New cocktail aims to tame transplant complications
NCT ID NCT05621759
First seen Jan 31, 2026 · Last updated Apr 30, 2026 · Updated 8 times
Summary
This study tests whether a lower dose of certain drugs can prevent graft-versus-host disease (GVHD) in adults receiving a stem cell transplant from a half-matched donor. GVHD is a serious condition where donor cells attack the patient's body. The trial uses a combination of three medications to reduce this risk. 27 adults with blood cancers are participating.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.